登出

Recap: Vanda Pharma Q2 Earnings

綜述：Vanda Pharma第二季度收益

Benzinga Real-time News · 2022/08/03 17:10

Vanda Pharma (NASDAQ:VNDA) reported its Q2 earnings results on Wednesday, August 3, 2022 at 04:00 PM.

萬達製藥納斯達克(股票代碼：VNDA)於2022年8月3日(星期三)下午04：00公佈了第二季度收益業績。

Here's what investors need to know about the announcement.

以下是投資者需要知道的關於這一聲明的信息。

Vanda Pharma missed estimated earnings by 54.55%, reporting an EPS of $0.05 versus an estimate of $0.11.

萬達製藥的每股收益低於預期54.55%，每股收益為0.05美元，低於預期的0.11美元。

Revenue was down $3.51 million from the same period last year.

營收比去年同期下降了351萬美元。

Last quarter the company missed on EPS by $0.1 which was followed by a 2.04% drop in the share price the next day.

上個季度，該公司每股收益比預期低0.1美元，第二天股價下跌2.04%。

Here's a look at Vanda Pharma's past performance:

以下是Vanda Pharma過去的表現：

Quarter	Q1 2022	Q4 2021	Q3 2021	Q2 2021
EPS Estimate	-0.01	0.08	0.16	0.14
EPS Actual	-0.11	0.12	0.14	0.17
Revenue Estimate	58.00M	70.04M	75.00M	69.75M
Revenue Actual	60.19M	68.02M	70.09M	67.90M

季度	Q1 2022	Q4 2021	Q3 2021	Q2 2021
每股收益預估	-0.01	0.08	0.16	0.14
實際每股收益	-0.11	0.12	0.14	0.17
收入預估	58.00M	70.04M	75.00M	69.75M
實際收入	60.19M	68.02M	70.09M	67.90M

To track all earnings releases for Vanda Pharma visit their earnings calendar here.

要跟蹤Vanda Pharma的所有收益發布，請訪問此處的收益日曆。

This article was generated by Benzinga's automated content engine and reviewed by an editor.

本文由Benzinga的自動內容引擎生成，並由編輯審閲。

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。更多信息

風險及免責聲明